Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ultragenyx Pharmaceutical Inc (RARE)  
$45.11 1.42 (3.25%) as of 4:30 Tue 4/23


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,110,000
Market Cap: 3.70(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.73 - $53.69
Level I Sector: Consumer Discretionary
Level II Sector: Leisure
Level III Sector: Restaurants

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    NASDAQ INDUSTRIAL     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 69,133 99,133 204,762 249,340
Total Sell Value $3,373,178 $4,809,278 $8,488,919 $10,478,837
Total People Sold 8 8 9 12
Total Sell Transactions 10 11 21 34
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 627
  Page 1 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Crombez Eric EVP and Chief Medical Officer   •       –      –    2024-04-18 4 S $44.10 $6,262 D/D (142) 48,785 2%     
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2024-04-16 4 D $42.31 $592 D/D (14) 41,366     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2024-03-11 4 S $49.93 $574,644 D/D (11,509) 252,823 13%     
   Fust Matthew K   –       •      –    2024-03-07 4 S $50.85 $620,443 D/D (12,195) 14,860 17%     
   Crombez Eric EVP and Chief Medical Officer   •       –      –    2024-03-01 4 S $53.76 $66,555 D/D (1,238) 48,927 21%     
   Crombez Eric EVP and Chief Medical Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 19,400 49,912     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2024-03-01 4 S $53.76 $18,332 D/D (341) 41,380 21%     
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2024-03-01 4 D $53.69 $6,496 D/D (121) 41,721     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 13,950 41,842     -
   Parschauer Karah Herdman EVP and Chief Legal Officer   •       –      –    2024-03-01 4 S $53.76 $201,923 D/D (3,756) 67,340 21%     
   Parschauer Karah Herdman EVP and Chief Legal Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 18,757 70,739     -
   Huang Dennis Karl See Remarks   •       –      –    2024-03-01 4 D $53.69 $25,234 D/D (470) 83,002     -
   Huang Dennis Karl See Remarks   •       –      –    2024-03-01 4 A $0.00 $0 D/D 18,757 83,472     -
   Horn Howard Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 19,400 99,766     -
   Kakkis Emil D President & CEO   •       •      –    2024-03-01 4 A $0.00 $0 D/D 41,560 563,913     -
   Kakkis Emil D President & CEO   •       •      –    2024-03-01 4 D $53.69 $935,119 D/D (17,417) 560,781     -
   Pinion John Richard See Remarks   •       –      –    2024-03-01 4 S $53.76 $224,340 D/D (4,173) 89,268 21%     
   Pinion John Richard See Remarks   •       –      –    2024-03-01 4 D $53.69 $3,221 D/D (60) 93,441     -
   Pinion John Richard See Remarks   •       –      –    2024-03-01 4 A $0.00 $0 D/D 18,757 93,501     -
   Harris Erik EVP & Chief Commercial Officer   •       –      –    2024-03-01 4 S $53.76 $256,328 D/D (4,768) 67,163 21%     
   Harris Erik EVP & Chief Commercial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 20,357 71,638     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2024-03-01 4 S $53.76 $54,351 D/D (1,011) 264,332 21%     
   Kassberg Thomas Richard CBO & EVP   •       –      –    2024-03-01 4 D $53.69 $14,711 D/D (274) 265,343     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2024-03-01 4 A $0.00 $0 D/D 18,757 265,617     -
   Kakkis Emil D President & CEO   •       •      –    2024-02-07 4 AS $45.00 $1,350,000 D/D (30,000) 539,770 -5%     
  627 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us